FDA approves first AI based COVID-19 non-diagnostic screening Kumar Jeetendra | March 21, 2021 Now, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the first machine learning-based Coronavirus Disease 2019 (COVID-19) non-diagnostic testing apparatus that identifies certain biomarkers that are indicative of some kinds of conditions, such as hypercoagulation (a condition causing blood to clot more readily than normal). The Tiger Tech COVID Plus …
Researchers discover proof that SARS-CoV-2 infects cells in the mouth Kumar Jeetendra | March 25, 2021 An international group of scientists has discovered evidence that SARS-CoV-2, the virus that causes COVID-19, infects cells in the mouth. While it’s well known that the upper airways and lungs are primary sites of SARS-CoV-2 disease, there are clues the virus can infect cells in different parts of the body, like the digestive system, blood …
Scientists use genetics to recognize likely drugs for early administration of COVID-19 Kumar Jeetendra | April 12, 2021 A new study using human genetics indicates researchers should prioritize clinical trials of drugs that target two proteins to manage COVID-19 in its early stages. The findings appeared online in the journal Nature Medicine at March 2021. The purpose is to identify present drugs, either FDA-approved or in clinical development for other conditions, that can …
Small SARS-CoV-2 protein may have huge ramifications for future COVID-19 medicines Kumar Jeetendra | April 12, 2021 A very small protein of SARS-CoV-2, the coronavirus that gives rise to COVID-19, may have big implications for future therapies, according to a team of Penn State researchers. Using a novel toolkit of approaches, the scientists uncovered the first full structure of the Nucleocapsid (N) protein and discovered how antibodies from COVID-19 patients interact with …
Study offers a non-obtrusive avenue for monitoring buildings for COVID-19 Kumar Jeetendra | April 14, 2021 A study done in rooms where COVID-19 patients were isolated reveals that the virus’s RNA – part of the genetic material inside a virus – can persist up to a month in dust. The study did not evaluate whether dust may transmit the virus to people. It could, however, offer another option for monitoring COVID-19 …
Three-sided molded spikes help the success of Covid transmission Kumar Jeetendra | April 16, 2021 COVID-19 requires no introduction. This past year, the disease, which is caused by the virus SARS-CoV-2, reached every continent across the globe. From the end of March 2021, there had been an estimated 128 million cases listed with nearly three million of these being deadly. As scientists’ race to produce vaccines and politicians coordinate their …
Researchers enlighten how a few antibodies can viably disable ebolaviruses Kumar Jeetendra | April 18, 2021 Some survivors of ebolavirus outbreaks create antibodies that may broadly neutralize those viruses–and today , scientists at Scripps Research have illuminated how these antibodies can disable the viruses so efficiently. The insights might be helpful for developing effective treatments. Ebolavirus is a family of often-deadly viruses that includes Ebola virus and lots of lesser-known viruses …
Antiviral T cells protected, viable as off-the-shelf treatment for painful complication stem cells Kumar Jeetendra | May 2, 2021 Infusion of T cells targeting BKV resulted in rapid responses, with 67.7% of patients seeing a complete or partial improvement in symptoms after 14 days. This increased to 81.6% of patients after 28 days post-infusion. No cases of grade 3 or grade 4 graft versus host disease (GVHD) or other infusion-related toxicities occurred. Addressing a …
Researchers examine signal necrotic cells that prompt phagocytic cells to overwhelm the dying cell Kumar Jeetendra | May 8, 2021 As people keep their homes clean and clutter in check, a crew of cells within the body is in charge of clearing the waste that the body generates, including cells that are dying. The housekeeping cells remove unwanted material by a process called phagocytosis, which literally means’eating cells’ “Phagocytosis is quite important for the body’s …
UCL researchers distinguish new immunotherapy to battle hepatitis B infection Kumar Jeetendra | May 15, 2021 Researchers at UCL have identified a new immunotherapy to fight the hepatitis B virus (HBV), the most frequent cause of liver cancer in the world. The pioneering study used immune cells isolated directly from patient liver and tumour tissue, to demonstrate that targeting acyl-CoA:cholesterol acyltransferase (ACAT), an enzyme which helps to manage cholesterol levels in …
Study gives significant knowledge to forestalling worldwide pandemics Kumar Jeetendra | May 17, 2021 Whether it’s plankton exposed to parasites or people exposed to pathogens, a host’s initial immune response plays an integral role in determining whether infection occurs and to what level it spreads within a population, new University of Colorado Boulder research indicates. From parasitic flatworms transmitted by snails into individuals in developing nations, to zoonotic spillover …
New COVID-19 testing innovation is a less expensive, quicker choice to tube-based RT-PCR tests Kumar Jeetendra | May 18, 2021 Throughout the COVID-19 pandemic, supply chain shortages of reagents and test kits have restricted the rapid expansion of clinical testing required to contain the virus. Its accuracy was 100 percent predictive in clinical trials, researchers explain in The Journal of Molecular Diagnostics, published by Elsevier. Sensitivity is critical for early detection of COVID-19 infection where …
